Drug Type Small molecule drug |
Synonyms Glubes, Mitiglinide/voglibose, Voglibose/mitiglinide + [3] |
Mechanism MGAM inhibitors(Maltase-glucoamylase inhibitors), Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (22 Apr 2011), |
Regulation- |
Molecular FormulaC10H21NO7 |
InChIKeyFZNCGRZWXLXZSZ-CIQUZCHMSA-N |
CAS Registry83480-29-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | JP | 22 Apr 2011 |